Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to DACOGEN Injection:
DACOGEN Injection is utilized in the treatment of a blood cancer called acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). It may also be prescribed for other conditions as determined by the doctor.
DACOGEN Injection is administered with certain other medications as part of combination chemotherapy. It is given as an intravenous injection under the supervision of a doctor. Your doctor will determine the necessary dose and frequency of administration based on your condition, which may change over time. It is crucial to adhere to your doctor's instructions precisely, as improper usage or overdose can lead to severe side effects. While it may take several weeks or months to observe the benefits, do not discontinue the medication unless instructed by your doctor.
Uses of DACOGEN Injection:
Myelodysplastic syndrome
Blood cancer (acute myeloid leukemia)
Benefits of DACOGEN Injection:
In Myelodysplastic syndrome:
DACOGEN Injection is effective in treating myelodysplastic syndrome, a group of conditions characterized by abnormal production of blood cells in the bone marrow. It works by inhibiting the growth of cancer cells and preventing their proliferation. Despite its efficacy, DACOGEN Injection is highly toxic, and discussions with your doctor regarding risks and benefits are essential. Additionally, it is advised to abstain from alcohol consumption during treatment and maintain hydration.
In Blood cancer:
DACOGEN Injection is also beneficial in the treatment of blood cancer, specifically acute myeloid leukemia. It works by halting the growth and multiplication of cancer cells, thereby restoring the body's ability to fight infection. While it is effective, discussions with your doctor regarding potential side effects and benefits are important. Any bothersome side effects should be promptly reported to your doctor.
Mechanism of Action of DACOGEN Injection:
DACOGEN Injection interferes with the growth of DNA and RNA in cancer cells by substituting their building blocks. This disruption prevents the cancer cells from growing and multiplying, ultimately inhibiting disease progression.